This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

News

View all

Connected Hospitals

Events, Seminars, & Publications | Monday 12 June 2023

Connected Hospitals

ATTIKON, B Pre-educational Clinic, Director Professor Ms. Amanda Psirri.
2nd Ambassador: Oncologist Ms. Panagiota Economopoulou. 

SOTIRIA, C Pathology Clinic, Director Professor Mr. Konstantinos Syrigos.
Scientific Responsible – 2nd Ambassador: Oncologist Ms. Orianthi Fiste. 

General Hospital LARISSAS, Dental Department for Disabled, Director Mr. Grigorios Vlahakis, Scientific Responsible Ms. Paraskevi Siafaka.
2nd Ambassador: Ms. Aikaterini Passa, Supervisor A. 

We sincerely thank and are grateful to the selected and prominent Hospitals of our Country, who chose to participate in the SymbIASIS program and to be associated with CureCancer - mycancer.gr.
Our goal is to record and evaluate their demographic, social and economic needs as well as elements of their disease and treatment, which may affect the patients themselves and people with cancer experience, as well as their families. A particular innovation of CureCancer - mycancer.gr is the fact that the data is filled in by the patients themselves.

Tags:

Events, Seminars, & Publications Monday 12 June 2023

Connected Hospitals

Connected Hospitals

ATTIKON, B Pre-educational Clinic, Director Professor Ms. Amanda Psirri.
2nd Ambassador: Oncologist Ms. Panagiota Economopoulou. 

SOTIRIA, C Pathology Clinic, Director Professor Mr. Konstantinos Syrigos.
Scientific Responsible – 2nd Ambassador: Oncologist Ms. Orianthi Fiste. 

General Hospital LARISSAS, Dental Department for Disabled, Director Mr. Grigorios Vlahakis, Scientific Responsible Ms. Paraskevi Siafaka.
2nd Ambassador: Ms. Aikaterini Passa, Supervisor A. 

We sincerely thank and are grateful to the selected and prominent Hospitals of our Country, who chose to participate in the SymbIASIS program and to be associated with CureCancer - mycancer.gr.
Our goal is to record and evaluate their demographic, social and economic needs as well as elements of their disease and treatment, which may affect the patients themselves and people with cancer experience, as well as their families. A particular innovation of CureCancer - mycancer.gr is the fact that the data is filled in by the patients themselves.

More news


Register with mycancer.gr today

Stay informed and up-to-date on the latest health care news and developments about your health care

Register now
Contact us